Michel Ducher

2.0k total citations · 1 hit paper
69 papers, 1.5k citations indexed

About

Michel Ducher is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Michel Ducher has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 17 papers in Pharmacology and 13 papers in Epidemiology. Recurrent topics in Michel Ducher's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Heart Rate Variability and Autonomic Control (14 papers) and Blood Pressure and Hypertension Studies (11 papers). Michel Ducher is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Heart Rate Variability and Autonomic Control (14 papers) and Blood Pressure and Hypertension Studies (11 papers). Michel Ducher collaborates with scholars based in France, United States and Australia. Michel Ducher's co-authors include Pascal Maire, Laurent Bourguignon, Sylvain Goutelle, Florent Rougier, Michel Maurin, Xavier Barbaut, Jean‐Pierre Fauvel, Catherine Cerutti, Jean Pierre Fauvel and Maurice Laville and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Michel Ducher

66 papers receiving 1.5k citations

Hit Papers

The Hill equation: a review of its capabilities in pharma... 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Ducher France 17 323 271 243 157 139 69 1.5k
Takehiro Yamada Japan 24 273 0.8× 312 1.2× 496 2.0× 110 0.7× 160 1.2× 120 1.9k
Eduardo Barbosa Coelho Brazil 24 351 1.1× 233 0.9× 199 0.8× 72 0.5× 155 1.1× 142 1.7k
Uwe Kobold Germany 20 194 0.6× 621 2.3× 129 0.5× 125 0.8× 183 1.3× 50 2.7k
Roy O. Mathew United States 23 308 1.0× 182 0.7× 189 0.8× 68 0.4× 309 2.2× 115 1.7k
Slobodan Јаnkovic Serbia 26 216 0.7× 358 1.3× 307 1.3× 54 0.3× 182 1.3× 406 3.0k
Thomas M Annesley United States 25 257 0.8× 987 3.6× 461 1.9× 169 1.1× 195 1.4× 99 3.7k
Marc G. Bogaert Belgium 21 191 0.6× 243 0.9× 282 1.2× 51 0.3× 183 1.3× 85 1.5k
Arik Eisenkraft Israel 22 152 0.5× 171 0.6× 119 0.5× 193 1.2× 182 1.3× 95 1.4k
Hans G. Schneider Australia 29 496 1.5× 537 2.0× 124 0.5× 85 0.5× 333 2.4× 147 2.8k
Paul M. Wax United States 31 269 0.8× 225 0.8× 443 1.8× 54 0.3× 129 0.9× 123 3.1k

Countries citing papers authored by Michel Ducher

Since Specialization
Citations

This map shows the geographic impact of Michel Ducher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Ducher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Ducher more than expected).

Fields of papers citing papers by Michel Ducher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Ducher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Ducher. The network helps show where Michel Ducher may publish in the future.

Co-authorship network of co-authors of Michel Ducher

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Ducher. A scholar is included among the top collaborators of Michel Ducher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Ducher. Michel Ducher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trần, Dũng, Michel Ducher, Denis Fouque, & Jean‐Pierre Fauvel. (2024). External validation of a 2-year all-cause mortality prediction tool developed using machine learning in patients with stage 4–5 chronic kidney disease. Journal of Nephrology. 37(8). 2267–2274. 1 indexed citations
2.
Neely, Michael, Teresa Rushing, Yves Bertrand, et al.. (2020). Intra-individual Pharmacokinetic Variability of Intravenous Busulfan in Hematopoietic Stem Cell-Transplanted Children. Clinical Pharmacokinetics. 59(8). 1049–1061. 25 indexed citations
3.
Ducher, Michel, et al.. (2019). Évaluation de l’autoquestionnaire ExSel® pour dépister une consommation excessive de sel chez les patients consultant en néphrologie. Annales de Cardiologie et d Angéiologie. 68(4). 275–278. 1 indexed citations
4.
Fauvel, Jean‐Pierre, François Gueyffier, Lutgarde Thijs, & Michel Ducher. (2018). Combined effect of renal function and serum potassium level in sudden cardiac death in aging hypertensive subjects. Hypertension Research. 41(6). 469–474. 7 indexed citations
5.
Ducher, Michel, Claire Mounier‐Véhier, Pierre Lantelme, et al.. (2015). Reliability of a Bayesian network to predict an elevated aldosterone-to-renin ratio. Archives of cardiovascular diseases. 108(5). 293–299. 9 indexed citations
6.
Kalbacher, Emilie, et al.. (2015). A Bayesian Model to Describe Factors Influencing Trough Levels of Vancomycin in Hemodialysis Patients. ˜The œNephron journals/Nephron journals. 131(2). 131–137. 10 indexed citations
7.
Bourguignon, Laurent, et al.. (2014). Study of relationship between volume of distribution and body weight application to amikacin. European Journal of Drug Metabolism and Pharmacokinetics. 39(2). 87–91. 2 indexed citations
8.
Zaoui, Philippe, et al.. (2013). Are Triplicate Urine Samples Necessary to Assess Albuminuria?. Nephron Clinical Practice. 122(3-4). 80–85. 4 indexed citations
9.
Ducher, Michel, et al.. (2012). Calcul de la première dose d’amikacine : évaluation des recommandations posologiques actuelles. Annales Pharmaceutiques Françaises. 71(1). 7–12. 1 indexed citations
10.
Uhart, M., et al.. (2011). Relation entre consommation de benzodiazépines et chutes en gériatrie : étude multicentrique dans trois établissements gériatriques d’un CHU. Annales Pharmaceutiques Françaises. 70(1). 46–52. 6 indexed citations
11.
Buron, Fanny, Laurence Dubourg, Emmanuel Morélon, et al.. (2011). Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Performance Over Time of Four Creatinine-Based Formulas. Transplantation. 92(9). 1005–1011. 60 indexed citations
12.
13.
Bourguignon, Laurent, et al.. (2009). Evaluation of various gentamicin dosage regimens in geriatric patients: a simulation study. Fundamental and Clinical Pharmacology. 24(1). 109–113. 10 indexed citations
14.
Ducher, Michel, Laurent Juillard, E. Leutenegger, & Jean Pierre Fauvel. (2008). Major Cardiovascular Risk Factors Are Not Taken Into Account by Physicians When Targeting Blood Pressure Values for Uncontrolled Hypertensive Patients. American Journal of Hypertension. 21(11). 1264–1268. 1 indexed citations
15.
Goutelle, Sylvain, Michel Maurin, Florent Rougier, et al.. (2008). The Hill equation: a review of its capabilities in pharmacological modelling. Fundamental and Clinical Pharmacology. 22(6). 633–648. 629 indexed citations breakdown →
16.
Ducher, Michel, Catherine Cerutti, André F. Marquand, et al.. (2005). How to limit screening of patients for atheromatous renal artery stenosis in two-drug resistant hypertension?. Journal of Nephrology. 18(2). 161–165. 6 indexed citations
17.
Ducher, Michel, Jean‐Pierre Fauvel, Michel Maurin, et al.. (2003). Sodium intake and blood pressure in healthy individuals. Journal of Hypertension. 21(2). 289–294. 22 indexed citations
18.
Ducher, Michel, D. S. Bertram, N Pozet, M. Laville, & Jean‐Pierre Fauvel. (2002). Stress-induced renal alterations in normotensives offspring of hypertensives and in hypertensives. American Journal of Hypertension. 15(4). 346–350. 10 indexed citations
19.
Ducher, Michel, et al.. (2001). Renal Elimination of Amikacin and the Aging Process. Clinical Pharmacokinetics. 40(12). 947–953. 15 indexed citations
20.
Fauvel, Jean Pierre, et al.. (1999). Effects of Rilmenidine on Stress-Induced Peak Blood Pressure and Renal Function. Journal of Cardiovascular Pharmacology. 34(1). 41–45. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026